Company

Be part of Algenex story

Mar 12 2021

Are you ready to take the leap with us? Here are our current job openings.

Laboratory Technician Downstream Processes

Requirements:

  • Previous experience in R&D or Manufacturing in DSP processes.
  • Experience in working with Tangential flow filtration systems, AKTA systems, UV spectrophotometer, balances, chromatography columns, SDS-PAGE, autoclaves, pH meter, refrigerators, freezers, biohazard safety cabinets.
  • Experience in protein analytical techniques: SDS-PAGE, Western Blot and ELISA.
  • Experience in general molecular biology techniques: cloning, PCR…
  • Experience in GMP environment is an advantage.
  • Confident in working in English.
  • Teamworker, out of the box thinker and eager to develop disruptive technologies.

Tasks:

  • Execute laboratory, development and production scale purification protocols as directed.
  • Prepare buffers and solutions.
  • Record results in laboratory notebooks; required to have meticulous organization and record keeping skills.
  • Communicate as a team member with other functional groups, via face to face, email and written reports.

 

Laboratory technician in entomology

Job title:

  • Insect rearing technician

Experience and training:

  • Previous experience in insect rearing at laboratory or industrial scale.
  • Preferably a technical background (no university degree).
  • Desirable: Minimum level of English A2
  • Soft skills: Clean and tidy, meticulous, observant, proactive, and a team player.

About Algenex

Algenex is a private biotechnology company developing disruptive baculovirus-based technologies for the production of recombinant biologics. Algenex´ first two platforms, TopBac® and CrisBio®, are based on baculovirus-based expression systems and have demonstrated their capacity to transform recombinant protein production through a process that provides almost unlimited and immediate scalability of manufacturing, production flexibility, simplicity and versatility while being extremely cost efficient.
To date, Algenex’ work has centred mainly on the development and production of veterinary vaccines, with > 200 molecules successfully produced in collaboration with public and private partners, including multiple international pharmaceutical companies. The first dossier for a veterinary vaccine produced in CrisBio® is currently being reviewed by EMA.

Algenex has now expanded the application of its proprietary and patented technologies into human health in order to fully exploit the potential of its platforms.

For more information, please visit Algenex.com.